The specificity of the
hypoglycemic response to the intrathecal (i.t.) administration of the naturally occurring (-)-enantiomer of
morphine previously reported from our laboratory was studied in mice. (+)-
Morphine HBr (50 micrograms) caused a behavioral syndrome (scratching, biting,
seizures) comparable to that produced by (-)-
morphine sulfate (50 micrograms), but did not cause
hypoglycemia. Many
opioids, at a dose of 50 micrograms i.t. in nonfasted mice, showed either a saline-like hyperglycemic response or no significant effect on
blood glucose. (+)-
Morphine,
ketocyclazocine, U-50,488, (-)- and (+)-N-allyl-
normetazocine,
beta-endorphin, (-)- and (+)-
naloxone and
naltrexone caused
hyperglycemia. Significant changes from basal
blood glucose were not produced by [
D-Pen2, L-Pen5]-enkephalin, [D-Ser2]-
Leu-enkephalin-Thr or
sufentanil in 50-micrograms doses, or by
codeine (300 micrograms),
levorphanol (400 micrograms) or
methadone (200-400 micrograms). Agonists which produced both
hypoglycemic and behavioral effects were, in order of decreasing potency,
hydromorphone greater than
normorphine greater than
morphine greater than
6-acetylmorphine greater than
oxymorphone much greater than
heroin.
Morphine-induced
hypoglycemia was partially antagonized by the i.t. coadministration of
naloxone methobromide (10 micrograms). Fasting for 24 hr increased the sensitivity to
hypoglycemic and lethal effects of
morphine. D-Ala2-N-Me-Phe4-Gly5-ol]-
enkephalin (5-50 micrograms i.t.) tended to decrease
blood glucose in both nonfasted and fasted mice, but these effects were moderate and appeared to be unrelated to dose.(ABSTRACT TRUNCATED AT 250 WORDS)